Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Inthepezon Aug 19, 2021 12:55pm
117 Views
Post# 33730967

RE:RE:RE:RE:RE:RE:Otenaproxesul and COVID-19 Data

RE:RE:RE:RE:RE:RE:Otenaproxesul and COVID-19 DataYour r3tardation knows no limits. But I know it’s just FUD. They millions upon millions of shares. If they really felt the ship was going down they would sell and no give a cr@p about retailers or the company, and treat it as a sunk cost. 

Just shut up and move on if you think it’s hopeless. You’re obviously scalping. What’s the point constantly saying the same thing. 

Youre so pathetically transparent. 


Rarbar99 wrote: Jesus Christ you're not the brightest tool in the shed, that's for sure.

Of course they're not going to sell. The stock has already crashed 70% and if any of them dared sell, the company would tank even further and delist. All institutions would flee and so would most retailers. If a drug company pauses a testing over complications, tanks in value, and then insiders start selling, that's when you know the company is dead.

They will have to hold onto their shares whether they like it or not. But if they were really not worried and thought this was an overreaction, they would be buying the hell out of this dip. But they're not.


<< Previous
Bullboard Posts
Next >>